Introduction

Diabetes mellitus is associated with widespread atherosclerosis and subsequent cardiovascular complications. Apart from glycemic and comorbidity control, it is crucial in pre-clinical evaluation before the at-risk patients develop further vascular damage [1]. The brachial ankle pulse wave velocity (baPWV) is well established as a marker for arterial stiffness in systemic atherosclerotic diseases. Previous studies have demonstrated a significant association between baPWV and vascular structure changes and known risk factors for cardiovascular diseases [2, 3]. Microvascular function is believed to be impaired in early stage of atherosclerosis. However, only a limited number of studies have investigated the mutual relationship among various surrogate markers in systemic arterial trees such as the baPWV and microvascular indicators. Little is known about whether the levels of these functional markers exacerbate simultaneously in subclinical atherosclerosis and whether the cardiovascular risk factors contribute to their deterioration.

Skin perfusion can be evaluated by laser Doppler technique and coupled with various reactivity tests to challenge hyperemia response [4, 5]. A near-infrared laser beam is delivered to the target skin area via an optical-fiber probe. The light will be scattered from moving erythrocytes within the upper horizontal vascular plexus of the skin. The reflected light will undergo a frequency shift. The cutaneous microcirculation can be characterized by the amplitude and distribution of the frequency spectrum. The spectral analysis of basal and stimulated flow motion changes can be a functional indicator of microvascular regulation. The study of spectral intensity and distribution may provide insight into relative contributions of endothelial, neural and myogenic activity on skin perfusion changes [6, 7]. Impaired skin flow motion should be related to systemic vascular dysfunction, accounting in part for the greater cardiovascular risk in diabetes [7]. It is essential to identifying the association between microvascular functional markers and arterial stiffness, in order to elucidate early atherosclerotic changes and prevent the at risk patients from further vascular injury.

This study investigated the relationship between microvascular components and baPWV in type 2 diabetes with preclinical atherosclerosis. The post-occlusive vasomotor changes in skin perfusion were studied in type 2 diabetes with and without microalbuminuria. The diabetes with elevated urinary albumin excretion reflects microvascular deterioration predisposing an individual to atherosclerotic changes [1, 8]. The association between conduit artery function and microcirculatory control was assessed using baPWV and laser Doppler flow motion changes. It was hypothesized that reactive vasomotor changes might be impaired in type 2 diabetes with early stage atherosclerosis and its severity might be related to systemic arterial stiffness.

Methods

Study population

Among the diabetic outpatients receiving recent annual survey in a veterans’ affair medical center, a total of 65 type 2 diabetic patients were included in this study. A control group of 27 non-diabetic volunteers was recruited from the community. All participants gave their written informed consent to this study, which had been approved by the ethics committee of the hospital. None of the subjects had a history of skin ulceration or abnormal ankle brachial pressure index (< 0.9 or > 1.4) in their feet. The patients receiving α-, β-adrenergic blocker, direct-acting vasodilator, or calcium antagonists were excluded from this study. However, the use of angiotensin converting enzyme inhibitor, angiotensin II receptor blocker, or diuretics was allowed in this study.

The diabetic patients were evaluated and categorized based on the ratio of urine albumin-to-creatinine (UACR). The subjects with UACR < 30 mg/ g Cr were included in the normoalbuminuria (NAU) group. The UACR in the microalbuminuria (MAU) group was between 30 and 300 mg/g Cr. The three groups were matched for age (within 5 years), gender composition, and body mass index (BMI) (within 3 kg/m2). The clinical characteristics of the studied groups are shown in Table 1.

Table 1 Clinical characteristic of type 2 diabetic patients and nondiabetic controls

baPWV

The participants were requested to assume supine position for at least 10 min in the air-conditioned room with a constant temperature of 25 ± 1 °C. The baPWV was measured using an automatic oscillometric device (VP-1000, Omron Healthcare Company, Kyoto, Japan) with pressure cuffs wrapped on the brachium and ankles. Repeated measurements were performed at 10-s intervals via automatic gain analysis. The left and right baPWV were calculated for the final mean values. Details of the method have been described previously [9].

Post-occlusive reactive hyperemia by laser Doppler flowmetry

Post-occlusive reactive hyperemia was assessed at the dorsum of right big toe using a laser Doppler flowmetry (MSP310XP; Oxford Optronix, Oxford, UK) with a sampling rate of 100 Hz. Occlusive ischemia was produced by a pneumatic cuff positioned at the right ankle and inflated up to 30 mm Hg above the systolic blood pressure. After 3 min of arterial occlusion, the pneumatic cuff was deflated. Skin perfusion was measured for 10 min under basal conditions, during 3 min of ischemia compression, and for 10 min following the pneumatic cuff release.

The laser Doppler flux signals were expressed as arbitrary units (AU) and transformed for subsequent analysis with validated custom-built computer programs [7]. Spectral amplitude was shown as a function of time and frequency after the wavelet transformations of skin perfusion signals (Fig. 1A). The three-dimensional time–frequency plot was then projected into two dimensions as averaged within a given period of time (Fig. 1B). The low-frequency interval was divided into three subintervals: 0.0095–0.021, 0.021–0.052, and 0.052–0.145 Hz corresponding to endothelial, neurogenic, and myogenic related activities [10]. The absolute spectral amplitudes of each frequency subinterval were averaged during 5 min before ischemia and during 5 min after the peak of post-ischemic reactive hyperemia. To obtain the relative contribution of a particular spectral subinterval within the full frequency range, the normalized or relative amplitude was defined as the ratio of the sum of spectral amplitudes within a given subinterval to the total spectral amplitudes of all sampled frequency contents based on the published method [11].

Fig. 1
figure 1

After the wavelet transformations of skin perfusion signals, spectral amplitude is shown as a function of time and frequency (A) and averaged in a given time interval as distributed in the low-frequency range (B)

Statistical analysis

The SPSS Statistics 21.0 (IBM Corporation, USA) was used for data analysis. The spectral amplitudes of skin perfusion were not normally distributed, and all values were log transformed before analysis. One-way ANOVA with post hoc analysis by Tukey’s least significant difference test was performed to compare the spectral parameters among three groups. Pearson’s correlation coefficients were utilized to assess the degree of association between multiple variables and baPWV. The independent contributions of clinical and vasomotor factors to baPWV were explored by stepwise regression analysis. A double-sided P-value of less than 0.05 was considered statistically significant.

Results

The clinical characteristics are shown in Table 1. The patients with incipient nephropathy were characterized by longer duration of diabetes. Although the two diabetic groups had similar HbA1c and systemic blood pressure, a higher proportion of MAU patients used concomitant medications for comorbidity such as hypertension or dyslipidemia (P < 0.01). The baPWV values were not significantly different between MAU and NAU groups.

The average amplitudes of the three divided subintervals were obtained for the frequency range from 0.0095 to 0.145 Hz in Table 2. No significant difference was noted in the mean spectral amplitude in each frequency interval between groups under basal conditions. Following occlusive ischemia, there was a significant increase in absolute spectral amplitude within the three sub-intervals (P < 0.01). The post-ischemic change divided by basal flow motion was presented as the percentage changes in Fig. 2. The MAU patients showed a lower post-ischemic percent change than the other groups (183% vs. 212% and 225%, P < 0.05) within the 0.0095–0.021 Hz frequency range related to endothelial activity. The other subintervals did not differ statistically in vasomotor change after ischemia among the three groups.

Table 2 Basal and post-ischemic spectral amplitude of three frequency intervals
Fig. 2
figure 2

Post-ischemic vasomotor changes in three frequency intervals from basal flow motion in percentage for three studied groups

For further comparison among three frequency subintervals, the spectral amplitude of a subinterval was normalized by the spectral amplitude of the full frequency range. The normalized spectral values of the three subintervals are shown for each group in Table 3. Under basal conditions, the mean normalized amplitudes of the three frequency intervals were not significantly different among three groups. Following ischemia, the MAU patients showed a lower normalized value of endothelial interval compared to the NAU subjects, together with a higher normalized value of myogenic interval (P < 0.05). However, the difference was not significant when looking at the absolute frequency spectrum.

Table 3 basal and post-ischemic normalized spectral values of three subintervals

Among the aforementioned vasomotor components, only the post-ischemic endothelial percent change and normalized myogenic value revealed significant differences between groups. The two vasomotor variables were taken for further correlation and regression analysis. Correlation coefficients were obtained between vasomotor and clinical variables and baPWV. Among conventional risk factors, only the diabetes duration (r = 0.35, P < 0.05) and HbA1C (r = 0.29, P < 0.05) had a significant positive correlation with the baPWV. No significant correlation was noted between baPWV and BMI, systolic blood pressure, and comorbidity treatment. The baPWV was negatively correlated to the changes in reactive flow motion of the endothelial interval (r = − 0.48, P < 0.01) and normalized myogenic value (r = − 0.37, P < 0.05). The microvascular variables showed more significant associations with baPWV than conventional risk factors.

Stepwise multiple regression analysis revealed that when endothelial flow motion change, normalized myogenic value, diabetes duration, glycosylated hemoglobin value, and the uses of comorbidity medication were included as the determinants of baPWV, only reactive endothelial vasomotor changes independently contributed to the variance of baPWV [OR 3.47 (95% CI 1.63–7.42), P < 0.05].

Discussion

Previous studies have revealed that the diabetes per se accelerate atherosclerotic changes in the arterial wall. Some diabetic patients have changed extracellular matrix composition in capillary basement membranes [12]. Vessel function could be influenced by the structural changes in atherosclerotic diseases. The functional deterioration has been quantified by prior investigators but the results varied [13, 14]. Systemic microangiopathy can be studied in patients with concomitant cardiovascular diseases. Widespread atherosclerosis seemed to play a certain role in the pathogenesis of diabetic vascular diseases or as a consequence of these complications [15]. Numerous studies have found possible link between albuminuria and enhanced cardiovascular risks in diabetes [16, 17]. This association is independent of conventional risk factors. This study evaluated the diabetic patients with microalbuminuria as a model to assess microvascular function in early stage of atherosclerosis.

The skin offers an alternative approach to the microcirculatory changes in patients with diabetes. The altered skin perfusion response to ischemia is a complex phenomenon, which includes local NO-mediated endothelial activity, the influence of perivascular nerve, and smooth muscle responsiveness [18]. Previous studies revealed that reactive skin perfusions in response to various stimuli were preserved in chronic nephropathy patients [19, 20]. By measuring post-occlusive perfusion response, our study did not find significant differences between diabetes with and without incipient nephropathy. However, Schmiedel et al. indicated that diabetic microalbuminuria patients have impaired vasodilatory response to endothelium dependent stimuli [21]. These findings suggested that the stimulated perfusion varied from one subject to another even if they had similar medical condition. The degree of impairment depended not only on the severity of the cardiovascular diseases but also on their associated microangiopathy.

Previous studies have found the uremic patients to be with impaired low-frequency oscillations in response to endothelium-dependent stimuli [11, 22, 23]. Our research extended prior observations of reactive hyperemia by wavelet analysis into more refined frequency range of interest. This study revealed that diabetic patients with microalbuminuria had reduced flow motion changes in very low frequency interval. Our findings were consistent with impaired flow motion in corresponding endothelial range in previous uremic patients [11, 23, 24]. The dysregulated skin microcirculation could be related to the endothelial dysfunction in either overt or subclinical atherosclerosis. Our study gave some insights into the extent of the possible mechanisms involved in disordered reactive hyperemia. It is interesting to note that a relative change was present in spectral distribution of neurogenic and myogenic flow motion following ischemia. Our results implied that microvascular perfusion might be disturbed with additional endothelial-independent components in patients with incipient nephropathy.

This study found that post-ischemic increase in the normalized myogenic component showed significant inverse association with the arterial stiffness. The smooth muscle dysfunction should be related to the severity of atherosclerosis. Previous study has indicated that the severity of postural hypotension was negatively correlated with myogenic vasomotor amplitude [7]. Our findings were consistent with the established close relation between smooth muscle dysfunction and severe cardiovascular complications [25, 26]. This study revealed that various microcirculatory markers would not deteriorate to the same degree in subclinical atherosclerosis. The endothelial control seemed to be dysfunctional first, leaving the neurogenic and myogenic regulation intact in microvasculature [27, 28]. Therefore, impaired systemic vascular tone was likely to develop in advanced atherosclerotic diseases, leading to symptomatic vascular insufficiency.

The vessel diameter changes are related to rhythmic constriction and dilation of arteriolar smooth muscles. The vasomotor responses contribute to lowering the resistance and increasing the perfusion pressure in microvasculature [29, 30]. Diabetes involving peripheral vascular structure could reduce the magnitude of the locally driven vessel diameter changes. Our study indicated that there was impaired microvascular flow motion in patients with early atherosclerosis even in the absence of large vessel disease. Increased vasomotor output could be a part of the normal physiological response to compensate for impaired tissue perfusion [31, 32]. The microalbuminuria patients are at risk of systemic vascular insufficiency as a result of their inability to mount this response. Our data can be interpreted as the functional alteration within small arteriole such as diminished endothelial activity together with increased myogenic activity in preserved reactive hyperemia perfusion. These results suggested that spectral distribution changes preceded the development of disturbed skin perfusion or spectral power. That could be the reason why the structural perfusion changes did not occur in the early stage of atherosclerosis.

Impaired vascular function has been studied in both microvascular and macrovascular tissues and possible association could be estimated among various surrogate markers. Tao et al. indicated that systemic arterial elasticity deteriorated parallel with cutaneous microvascular flow changes [33]. However, lack of correlation was shown between conduit vessel response and laser Doppler measures of skin perfusion by previous studies [34, 35]. The various tests characterized distinct vascular pathologies in patients at cardiovascular risks. The use of different vascular bed may account for the aforementioned heterogeneous findings. This study advocated the pulse wave analysis to investigate the entire vascular pathway including central elastic and peripheral muscular arteries. This post-ischemic increase in vasomotor component was included as a surrogate marker as well for microcirculatory function.

Reactive vasomotion and pulse wave velocity represented different clinical implications in patients with preclinical atherosclerosis. The distinct vascular assessment can be integrated in this study using the regression model. Multiple regression analysis revealed that reduced endothelial flow motion changes independently contributed to increased pulse wave velocity. This study indicated that the impairment degree of reactive flow motion could reflect increased baPWV to some extent. These findings may underlie the association between diabetic microangiopathy and arterial stiffness. The associations were independent of other clinical covariates. This study highlighted the importance of early detection of subclinical atherosclerotic diseases in diabetic patients.

The limitation of this study was that the analysis of various degrees of vasculopathy might not be conclusive enough owing to a small sample size in each subgroup. The regression model could only be used to predict the patients with minor cardiovascular risks. The skin perfusion could only be expressed as arbitrary units, and it was difficult to define the threshold level for the normality and to be compared with other relevant reports. Our findings demonstrated a less robust but still significant relationship between arterial stiffness and reactive vasomotor changes. Further investigations are needed to clarify whether these microvascular changes are present in some target organs other than cutaneous tissues. The pathological basis and the temporal relationships of these associations must be explored by additional mechanistic and prospective studies to understand the clinical significance of these findings.

Conclusion

The spectral analysis of laser Doppler skin perfusion provided insights into potential significance of microcirculatory control in the development of macrovascular dysfunction. Various microvascular markers would not deteriorate to the same degree in subclinical atherosclerosis. Reduced endothelial related change was noted first, followed by frequency spectrum redistribution. Impaired reactive flow motion and arterial stiffness correlated with each other. The associations were possibly related to subclinical atherosclerosis and independent of conventional risk factors. The functional adjustment could precede structural perfusion insufficiency in incipient vasculopathy patients.